Beijing Tong Ren Tang Co.,Ltd.(600085),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

600085 Beijing Tong Ren Tang Co.,Ltd.

Closed 12-19 15:00:00

32.42

+0.09

+0.28%

High32.61	Low32.32	Vol5.42M
Open32.34	D1 Closing32.33	Amplitude0.90%
Mkt Cap44.45B	Tradable Cap44.45B	Total Shares1.37B
T/O176.00M	T/O Rate0.40%	Tradable Shares1.37B
P/B3.25	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"600085","market":"SH","secType":"STK","nameCN":"Beijing Tong Ren Tang Co.,Ltd.","latestPrice":32.42,"timestamp":1766127600000,"preClose":32.33,"halted":0,"volume":5424101,"delay":0,"changeRate":0.0028,"floatShares":1371000000,"shares":1371000000,"eps":0.9871,"marketStatus":"Closed","change":0.09,"latestTime":"12-19 15:00:00","open":32.34,"high":32.61,"low":32.32,"amount":176000000,"amplitude":0.009,"askPrice":32.46,"askSize":36,"bidPrice":32.42,"bidSize":283,"shortable":0,"etf":0,"ttmEps":0.9871,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":32.33,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":35.56,"lowLimit":29.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1371470262,"isCdr":false,"pbRate":3.25,"roa":"--","peRate":32.843684,"roe":"8.72%","epsLYR":1.113,"committee":0.414698,"marketValue":44463000000,"turnoverRate":0.004,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-12-22.","floatMarketCap":44463000000},"requestUrl":"/m/hq/s/600085/wiki","defaultTab":"wiki","newsList":[{"id":"1134278059","title":"Tong Ren Tang Group Issues Statement: Conducting Thorough Investigation into Involved Products, Vowing to Get to the Bottom of the Matter","url":"https://stock-news.laohu8.com/highlight/detail?id=1134278059","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134278059?lang=en_us&edition=fundamental","pubTime":"2025-12-20 09:50","pubTimestamp":1766195433,"startTime":"0","endTime":"0","summary":"On the morning of December 20, Beijing Tong Ren Tang Co., Ltd. (600085) released an official statement addressing recent public concerns regarding its \"Antarctic Krill Oil\" products. The company...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0012","600085","BK0188","BK0183","LU1688375341.USD","BK0196","BK0086","BK0097","BK0113","BK0028"],"gpt_icon":0},{"id":"1148341539","title":"Tong Ren Tang's Brand Crisis: Dual Challenges of Licensing Chaos and Declining Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1148341539","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148341539?lang=en_us&edition=fundamental","pubTime":"2025-12-17 15:11","pubTimestamp":1765955461,"startTime":"0","endTime":"0","summary":"Beijing Tong Ren Tang Co., Ltd., a time-honored brand with a century-long history, has recently been embroiled in controversy over its \"Antarctic Krill Oil\" product. The Shanghai Consumer Council's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0012","LU1688375341.USD","600085","BK0028","BK0183","BK0196","BK0113","BK0188","BK0097","BK0086"],"gpt_icon":0},{"id":"1101194728","title":"Tong Ren Tang Product Suspected of Fraud? Official Response: Orders to Halt Distribution, Legal Action Against Involved Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1101194728","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101194728?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:10","pubTimestamp":1765800630,"startTime":"0","endTime":"0","summary":"On December 15, Tong Ren Tang Health issued a statement addressing recent media reports alleging false labeling of a product named \"99% High-Purity Antarctic Krill Oil.\" The product was labeled as...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0239","BK0028","600085","BK0196","LU1688375341.USD","BK0113","BK0097","BK0086","BK0188","BK0183"],"gpt_icon":0},{"id":"1180904985","title":"Tong Ren Tang Responds to Krill Oil Fraud Allegations: Launches Full Investigation and Traceability of Involved Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1180904985","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180904985?lang=en_us&edition=fundamental","pubTime":"2025-12-15 18:10","pubTimestamp":1765793430,"startTime":"0","endTime":"0","summary":"On December 15, the official WeChat account \"Tong Ren Tang Health Member\" issued a statement addressing media reports about a product labeled as \"99% High-Purity Antarctic Krill Oil,\" allegedly...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","LU1688375341.USD","BK0239","BK0012","BK0188","BK0086","BK0113","BK0097","BK0183","600085","BK0028"],"gpt_icon":0},{"id":"2590945360","title":"Tong Ren Tang's Stomach TCM Gains Canadian Product License","url":"https://stock-news.laohu8.com/highlight/detail?id=2590945360","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590945360?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:12","pubTimestamp":1765242738,"startTime":"0","endTime":"0","summary":"Beijing Tong Ren Tang  has secured a Canadian registration for its traditional Chinese medicine  product, Shenling Baizhu Powder, according to a Shanghai Stock Exchange filing on Tuesday.The product is used to relieve symptoms of spleen and stomach weakness, such as poor appetite and loose stools. It can also relieve shortness of breath, cough and fatigue, the company said.The license serves as a product marketing authorization in Canada.The company has so far spent about 2.29 million yuan on the product's research and development.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0113","BK0188","BK0097","600085","BK0086","BK0239","LU1688375341.USD","BK0183","BK0196","BK0012","BK0028"],"gpt_icon":0},{"id":"1194480995","title":"Investigation into Authentic vs. Licensed \"Beijing Tong Ren Tang\" Products: Diverse Offerings, Varied Manufacturers—Genuine or White-Label?","url":"https://stock-news.laohu8.com/highlight/detail?id=1194480995","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194480995?lang=en_us&edition=fundamental","pubTime":"2025-12-06 19:00","pubTimestamp":1765018839,"startTime":"0","endTime":"0","summary":"Consumers searching online for \"Beijing Tong Ren Tang\" products often find themselves uncertain whether they’ve purchased genuine items or white-labeled versions—a common dilemma echoed across social...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","BK0188","BK0239","600085","BK0183","BK0028","BK0196","BK0086","BK0113","BK0012","LU1688375341.USD"],"gpt_icon":0},{"id":"2588728652","title":"Tongrentang to Renew Trademark License Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2588728652","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588728652?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:01","pubTimestamp":1764579667,"startTime":"0","endTime":"0","summary":"Beijing Tongrentang , through subsidiary Beijing Tongrentang Chinese Medicine, plans to renew a trademark license agreement with China Beijing Tongrentang , according to a Shanghai bourse filing on Saturday.The Chinese drugmaker's shares rose less than 1% at the close of Monday's trade.The deal, which was first signed in 2013, would have been terminated on Dec. 31, but the parties agreed to renew it for two more years.The pharmaceutical company proposed to enter into a supplemental agreement to review fee-exemption clauses in the deal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0196","BK0086","600085","BK0097","BK0012","BK0183","BK0028","BK0113","BK0239","BK0188","LU1688375341.USD"],"gpt_icon":0},{"id":"2586246783","title":"Tong Ren Tang Technologies Signs Three-Year Land Use Lease with Tong Ren Tang Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246783","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586246783?lang=en_us&edition=fundamental","pubTime":"2025-11-28 18:10","pubTimestamp":1764324625,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies Co. Ltd. has announced the renewal of a land use right leasing agreement with its ultimate controlling shareholder, Tong Ren Tang Holdings. Under the renewed agreement, the company will lease land located at No. 20, Nansanhuan Zhonglu, Fengtai District, Beijing, from Tong Ren Tang Holdings for a period of three years, commencing from 6 October 2025 to 5 October 2028. The transaction is subject to reporting, announcement, and annual review requirements under the Hong Kong Listing Rules, but does not require independent shareholders' approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDLbhNmpj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK1583","BK0188","BK0113","BK0196","BK0028","BK1515","BK1606","BK0097","BK1191","BK0012","600085","BK0239","BK0086","01666","LU1688375341.USD"],"gpt_icon":0},{"id":"2586788474","title":"Tong Ren Tang Technologies Co. Ltd. Announces Date for Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586788474","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586788474?lang=en_us&edition=fundamental","pubTime":"2025-11-28 17:46","pubTimestamp":1764323199,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies Co. Ltd. has announced that it will hold an extraordinary general meeting on Tuesday, 30 December 2025 in Beijing, the People's Republic of China. Shareholders will consider and vote on resolutions as set out in the notice convening the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on November 28, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL4ZpWx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK0097","600085","BK0028","BK0188","BK0196","BK0183","LU1688375341.USD","BK0012","01666","BK0086","BK0239","BK1606","BK1191","BK0113","BK1583"],"gpt_icon":0},{"id":"2586004492","title":"Tong Ren Tang Technologies Proposes Du Xin as New Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2586004492","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586004492?lang=en_us&edition=fundamental","pubTime":"2025-11-28 17:25","pubTimestamp":1764321951,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies Co. Ltd. has announced that Mr. Chen Fei will resign from his position as non-executive Director due to work adjustments. His resignation will become effective once a new non-executive Director is elected at an upcoming general meeting. The Board has proposed Ms. Du Xin as the new non-executive Director, pending approval by shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on November 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL2Sh45Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0239","BK1583","BK0028","BK1515","600085","BK0196","LU1688375341.USD","BK1191","BK0113","BK1606","BK0097","BK0086","BK0188","BK0183","01666"],"gpt_icon":0},{"id":"1146519687","title":"Beijing Tong Ren Tang Group's Acquisition of Tianjin Tong Ren Tang: New Developments in Century-Old Brand Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=1146519687","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146519687?lang=en_us&edition=fundamental","pubTime":"2025-11-16 22:11","pubTimestamp":1763302291,"startTime":"0","endTime":"0","summary":"The prolonged trademark dispute over the \"Tong Ren Tang\" brand may soon be resolved. According to the State Administration for Market Regulation's business concentration anti-monopoly system, Beijing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","600085","BK0028","BK0188","BK0196","BK0183","LU1688375341.USD","BK0012","BK0239","BK0086","BK0113"],"gpt_icon":0},{"id":"1110102260","title":"Century-Old Trademark Dispute Nears Resolution: Beijing Tong Ren Tang to Acquire 60% Stake in Tianjin Counterpart","url":"https://stock-news.laohu8.com/highlight/detail?id=1110102260","media":"Deep News","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110102260?lang=en_us&edition=fundamental","pubTime":"2025-11-16 20:50","pubTimestamp":1763297429,"startTime":"0","endTime":"0","summary":"The prolonged trademark dispute between two century-old Chinese pharmaceutical brands may finally reach a settlement. According to China's State Administration for Market Regulation, Beijing Tong Ren...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0196","BK0113","BK0086","BK0239","600085","BK0188","BK0183","LU1688375341.USD","BK0097","BK0012"],"gpt_icon":0},{"id":"1178029108","title":"Beijing Tong Ren Tang Co.,Ltd. (600085.SH): Hemp Seed Pills Obtain Product Registration in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=1178029108","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178029108?lang=en_us&edition=fundamental","pubTime":"2025-11-07 15:46","pubTimestamp":1762501570,"startTime":"0","endTime":"0","summary":"Beijing Tong Ren Tang Co.,Ltd. (600085.SH) announced that its subsidiary, Beijing Tong Ren Tang Pharmaceutical Factory, has received a \"Product License (Category III)\" issued by Health Canada. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0188","BK0097","BK0239","BK0028","BK0012","BK0196","LU1688375341.USD","BK0086","600085","BK0113"],"gpt_icon":0},{"id":"2579458828","title":"Tongrentang's Attributable Profit Slides 29% in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2579458828","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579458828?lang=en_us&edition=fundamental","pubTime":"2025-10-31 15:59","pubTimestamp":1761897579,"startTime":"0","endTime":"0","summary":"Beijing Tongrentang's  attributable profit fell 29% year over year to 232.1 million yuan in the third quarter, according to a Friday filing with the Shanghai bourse.The traditional Chinese medicine manufacturer logged basic earnings per share of 0.169 yuan, down 30% from the year-ago period.Operating income declined 13% year on year to 3.54 billion yuan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0012","LU1688375341.USD","600085","BK0028","BK0183","BK0196","BK0113","BK0188","BK0097","BK0086"],"gpt_icon":0},{"id":"1172025409","title":"Tong Ren Tang (600085.SH) Reports Q3 Results: Net Profit Attributable to Shareholders Drops 12.78% to RMB 1.178 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1172025409","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172025409?lang=en_us&edition=fundamental","pubTime":"2025-10-30 15:44","pubTimestamp":1761810250,"startTime":"0","endTime":"0","summary":"Beijing Tong Ren Tang Co.,Ltd. (600085.SH) released its third-quarter report for 2025. The company's total operating revenue for the first three quarters reached RMB 13.308 billion, representing a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600085","BK0183","BK0188","BK0097","BK0196","LU1688375341.USD","BK0086","BK0113","BK0012","BK0028","BK0239"],"gpt_icon":0},{"id":"2571108394","title":"Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2571108394","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571108394?lang=en_us&edition=fundamental","pubTime":"2025-09-30 12:05","pubTimestamp":1759205114,"startTime":"0","endTime":"0","summary":"Beijing Tong Ren Tang's  subsidiary, Tong Ren Tang Technologies , renewed two agreements with the company's controlling shareholder, China Beijing Tong Ren Tang , for two more years, according to a Shanghai bourse filing on Tuesday.The deal includes Tong Ren Tang Technologies' procurement of Chinese medicine raw materials and the sale of products between 2026 and 2028.The procurement is estimated to cap at 45.5 million yuan between January and August and the sales at 57.7 million yuan in the same period, the Chinese pharmaceutical company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1583","01666","BK0239","BK1191","BK0113","BK0188","TGRNF","BK1606","BK0028","BK4007","LU1688375341.USD","BK0183","BK0196","BK0012","BK0086","600085","BK0097"],"gpt_icon":0},{"id":"2570006359","title":"Tong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2570006359","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570006359?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:18","pubTimestamp":1758878337,"startTime":"0","endTime":"0","summary":"**Tong Ren Tang Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, \"Tong Ren Tang Angong Niuhuang Wan,\" to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL337J1g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0012","BK0113","LU1688375341.USD","600085","BK1515","BK1606","BK0188","BK0239","BK0097","BK1583","BK0028","03613","01666","BK0196","BK0086","BK0183"],"gpt_icon":0},{"id":"2566263963","title":"Tong Ren Tang Technologies Reports 7.69% Revenue Decline and 21.01% Profit Drop for H1 2025; EPS Falls to RMB0.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2566263963","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566263963?lang=en_us&edition=fundamental","pubTime":"2025-09-11 17:12","pubTimestamp":1757581943,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies Co. Ltd. announced its unaudited interim results for the six months ended 30 June 2025. The Group's revenue for this period was RMB 3.738 billion, marking a decrease of approximately 7.69% from RMB 4.050 billion for the same period in 2024. The profit attributable to owners of the Company was RMB 484 million, reflecting a decline of approximately 21.01% compared to RMB 582 million in the previous year. Earnings per share for the period were reported at RMB 0.26, down from RMB 0.33 in 2024. The Board has decided not to declare an interim dividend for the period ended 30 June 2025. The Company, involved in the manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, continues its operations without any reported changes in business strategy or significant operational updates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL7NBwQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01666","600085"],"gpt_icon":0},{"id":"1131637347","title":"Beijing Tong Ren Tang Co.,Ltd. Elects Wang Jixiong as Employee Representative Director for 10th Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=1131637347","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131637347?lang=en_us&edition=fundamental","pubTime":"2025-09-09 21:11","pubTimestamp":1757423485,"startTime":"0","endTime":"0","summary":"On the evening of September 9th, Beijing Tong Ren Tang Co.,Ltd. announced that Mr. Wang Jixiong has been elected as the employee representative director for the company's 10th Board of Directors.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0012","LU1688375341.USD","600085","BK0028","BK0183","BK0196","BK0113","BK0188","BK0097","BK0086"],"gpt_icon":0},{"id":"1171178748","title":"Beijing Tong Ren Tang Medical and Healthcare Plans Hong Kong IPO, Receives CSRC Filing Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1171178748","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171178748?lang=en_us&edition=fundamental","pubTime":"2025-09-01 13:31","pubTimestamp":1756704666,"startTime":"0","endTime":"0","summary":"On August 29, 2025, the International Cooperation Department of the China Securities Regulatory Commission issued a filing notice regarding Beijing Tong Ren Tang Medical and Healthcare Investment...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0113","BK0028","BK0196","BK0012","BK0086","BK0239","BK0188","600085","LU1688375341.USD","BK0183","BK0097"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-06-25","address":"北京市大兴区中关村科技园区大兴生物医药产业基地天贵大街33号","stockEarnings":[{"period":"1week","weight":0.0006},{"period":"1month","weight":-0.0622},{"period":"3month","weight":-0.0681},{"period":"6month","weight":-0.0867},{"period":"1year","weight":-0.2098},{"period":"ytd","weight":-0.1902}],"companyName":"北京同仁堂股份有限公司","boardCode":"AI0027","perCapita":"10373股","boardName":"医药制造业","registeredCapital":"137147万元","compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.0143},{"period":"3month","weight":0.0184},{"period":"6month","weight":0.1579},{"period":"1year","weight":0.1544},{"period":"ytd","weight":0.1607}],"survey":"　　北京同仁堂股份有限公司的主营业务是中成药的生产与销售。公司的主要产品是安宫牛黄丸、同仁牛黄清心丸、同仁大活络丸、六味地黄丸，金匮肾气。公司“中药制造测量学关键技术与标准及软件装备应用项目”荣获中国产学研合作创新与促进奖。","serverTime":1766261179112,"listedPrice":7.08,"stockholders":"132210人(较上一季度增加21.16%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beijing Tong Ren Tang Co.,Ltd.(600085),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beijing Tong Ren Tang Co.,Ltd.(600085) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beijing Tong Ren Tang Co.,Ltd.,600085,Beijing Tong Ren Tang Co.,Ltd.股票,Beijing Tong Ren Tang Co.,Ltd.股票老虎,Beijing Tong Ren Tang Co.,Ltd.股票老虎国际,Beijing Tong Ren Tang Co.,Ltd.行情,Beijing Tong Ren Tang Co.,Ltd.股票行情,Beijing Tong Ren Tang Co.,Ltd.股价,Beijing Tong Ren Tang Co.,Ltd.股市,Beijing Tong Ren Tang Co.,Ltd.股票价格,Beijing Tong Ren Tang Co.,Ltd.股票交易,Beijing Tong Ren Tang Co.,Ltd.股票购买,Beijing Tong Ren Tang Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beijing Tong Ren Tang Co.,Ltd.(600085),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beijing Tong Ren Tang Co.,Ltd.(600085) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction